title: Immunological aspects of patients with HIV-1 disease following immunization with recombinant gp160 (VaxSyn).
authors.affiliation: Department of Allergy and Clinical Immunology, University of Rome La Sapienza, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Guerra
authors.forename: G
authors.initials: G
authors.lastname: Ricci
authors.forename: M
authors.initials: M
authors.lastname: Carlesimo
authors.forename: A R
authors.initials: AR
authors.lastname: Varani
authors.forename: O
authors.initials: O
authors.lastname: Pontesilli
authors.forename: E
authors.initials: E
authors.lastname: Scala
authors.forename: I
authors.initials: I
authors.lastname: Mezzaroma
authors.lastname: Pierdominici
authors.forename: F
authors.initials: F
authors.lastname: Pandolfi
authors.forename: A
authors.initials: A
authors.lastname: Antinori
authors.forename: A
authors.initials: A
authors.lastname: De Luca
authors.forename: R
authors.initials: R
authors.lastname: Murri
authors.forename: A
authors.initials: A
authors.lastname: Ammassari
authors.forename: L
authors.initials: L
authors.lastname: Ortona
authors.forename: F
authors.initials: F
authors.lastname: Aiuti
mesh_terms: D016915:AIDS Vaccines / Q000008:administration & dosage* / Q000276:immunology; D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000628:therapy*; D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004311:Double-Blind Method; D005260:Female; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D016233:Immunotherapy, Active; D008297:Male; D014614:Vaccines, Synthetic / Q000008:administration & dosage* / Q000276:immunology; D015215:Zidovudine / Q000008:administration & dosage
chemical_list: D016915:AIDS Vaccines; D000998:Antiviral Agents; D014614:Vaccines, Synthetic; C053473:VaxSyn HIV-1 (gp160) vaccine; D015215:Zidovudine